Imodium A-d Ez Chews is a drug owned by Johnson And Johnson Consumer Inc Mcneil Consumer Healthcare Div. It is protected by 2 US drug patents filed in 2013 out of which all have expired. Based on its patents and exclusivities, its generic launch date is estimated to be Aug 26, 2021. Details of Imodium A-d Ez Chews's patents and their expiration are given in the table below.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| These drug patents focus on the other aspects of the drug like dosage, mode of administration (oral, tablet, capsules, liquids etc). | |||
| US6814978 | Process for preparing a soft tablet |
Aug, 2021
(3 years ago) |
Expired
|
| US5489436 | Taste mask coatings for preparation of chewable pharmaceutical tablets |
Feb, 2013
(11 years ago) |
Expired
|
US patents provide insights into the exclusivity only within the United States, but Imodium A-d Ez Chews is protected by patents in multiple countries. Understanding the full scope of patent protection is crucial in strategizing market entry. By looking at the broader patent landscape, you can identify markets with weaker patent protection which could be ideal generic entry points. The following section offers details on Imodium A-d Ez Chews's family patents as well as insights into ongoing legal events on those patents.
Imodium A-d Ez Chews's Family Patents
Explore Our Curated Drug Screens
Generic Launch
Generic Release Date:
Imodium A-d Ez Chews's generic launch date based on the expiry of its last outstanding patent is estimated to be Aug 26, 2021 (This date is subject to change depending upon the patent filing activities by the drug owner or exclusivity additions to its drug application)
Imodium A-d Ez Chews Generic API suppliers:
Loperamide Hydrochloride is the generic name for the brand Imodium A-d Ez Chews. 25 different companies have already filed for the generic of Imodium A-d Ez Chews, with Teva having the maximum number of approved applications. Check out the entire list of companies who have already received approval for Imodium A-d Ez Chews's generic
Alternative Brands for Imodium A-d Ez Chews
Imodium A-d Ez Chews which is used for treating symptoms of anxiety and panic disorders., has several other brand drugs using the same active ingredient (Loperamide Hydrochloride). Given below is the list of those companies and their brand drugs, to help you identify new opportunities, assess competitors, and plan your market strategies more effectively.
| Drug Owner | Drug Name | |
|---|---|---|
| J And J Consumer Inc |
|
Apart from brand drugs containing the same ingredient, some generics have also been filed for Loperamide Hydrochloride, Imodium A-d Ez Chews's active ingredient. Check the complete list of approved generic manufacturers for Imodium A-d Ez Chews
About Imodium A-d Ez Chews
Imodium A-D Ez Chews is a drug owned by Johnson And Johnson Consumer Inc Mcneil Consumer Healthcare Div. It is used for treating symptoms of anxiety and panic disorders. Imodium A-D Ez Chews uses Loperamide Hydrochloride as an active ingredient. Imodium A-D Ez Chews was launched by J And J Consumer Inc in 1997.
Approval Date:
Imodium A-d Ez Chews was approved by FDA for market use on 24 July, 1997.
Active Ingredient:
Imodium A-d Ez Chews uses Loperamide Hydrochloride as the active ingredient. Check out other Drugs and Companies using Loperamide Hydrochloride ingredient
Treatment:
Imodium A-d Ez Chews is used for treating symptoms of anxiety and panic disorders.
Dosage:
Imodium A-d Ez Chews is available in tablet, chewable form for oral use. Given below is detailed information on Dosage -
| Strength | Dosage Form | Availability | Application Pathway |
|---|---|---|---|
| 2MG | TABLET, CHEWABLE | Discontinued | ORAL |